Evotec Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| IDXX | IDEXX Laboratories | Outperform |
14
|
$543.45 | Buy/Sell | $583.92 | 7.28% | 0 | $44.88B |
| IQV | IQVIA Holdings | Outperform |
15
|
$231.18 | Buy/Sell | $267.27 | 18.95% | 19 | $42.12B |
| ICLR | ICON Public | Buy |
16
|
$314.72 | Buy/Sell | $306.07 | 14.39% | 1 | $26.02B |
| ARGX | argenx | Outperform |
4
|
339.90€ | Buy/Sell | 531.81€ | 28.39% | 10 | 20.20€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.04k | Buy/Sell | kr2.71k | 29.35% | 14 | kr131.83B |
| SRT3 | Sartorius | Outperform |
18
|
268.50€ | Buy/Sell | 281.57€ | 22.91% | 10 | 16.67€B |
| LH | Laboratory Corp of America Hol... | Outperform |
11
|
$210.59 | Buy/Sell | $241.28 | 14.92% | 9 | $17.75B |
| SGSN | SGS | Hold |
18
|
CHF80.72 | Buy/Sell | CHF86.34 | 11.50% | 7 | CHF15.28B |
| DGX | Quest Diagnostics | Outperform |
10
|
$144.34 | Buy/Sell | $141.17 | 0.46% | 8 | $16.03B |
| BVI | Bureau Veritas | Outperform |
18
|
27.52€ | Buy/Sell | 26.96€ | 12.65% | 12 | 12.88€B |
| MEDP | Medpace Holdings | Outperform |
14
|
$393.30 | Buy/Sell | $281.20 | 14.92% | 2 | $12.34B |
| ERF | Eurofins Scientific | Hold |
18
|
58.26€ | Buy/Sell | 0.00€ | 2.99% | 5 | 11.05€B |
| CRL | Charles River Laboratories Int... | Outperform |
16
|
$221.61 | Buy/Sell | $229.97 | 21.84% | 11 | $11.82B |
| REC | Recordati Industria Chimica e ... | Hold |
18
|
51.20€ | Buy/Sell | 48.61€ | 0.49% | 1 | 10.36€B |
| ITRK | Intertek Group | Outperform |
18
|
£49.54 | Buy/Sell | £44.87 | 6.58% | 14 | £8.15B |
| CTLT | Catalent | Hold |
15
|
$55.37 | Buy/Sell | $49.29 | 14.68% | 3 | $10.10B |
| SHL | Sonic Healthcare | Hold |
18
|
$26.63 | Buy/Sell | $34.12 | 16.41% | 0 | $12.78B |
| BANB | Bachem Holding | Hold |
16
|
CHF90.60 | Buy/Sell | CHF616.00 | -11.70% | 2 | CHF6.25B |
| ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr600.00 | Buy/Sell | kr357.00 | 35.83% | 2 | kr38.52B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.78 | Buy/Sell | £28.11 | 47.67% | 9 | £4.42B |
| ORNBV | Orion Oyj | Hold |
14
|
37.69€ | Buy/Sell | 42.52€ | 11.44% | 3 | 5.12€B |
| ABCM | Abcam | - |
18
|
$23.99 | Buy/Sell | $19.25 | -67.15% | 0 | $5.52B |
| ALK B | ALK-Abelló A/S | Outperform |
13
|
kr152.00 | Buy/Sell | kr109.25 | 8.55% | 3 | kr33.91B |
| TECN | Tecan Group | Outperform |
18
|
CHF333.20 | Buy/Sell | CHF406.33 | 20.05% | 3 | CHF4.40B |
| MOR | MorphoSys | Hold |
6
|
69.35€ | Buy/Sell | 28.78€ | -1.95% | 3 | 2.52€B |
| SYNH | Syneos Health | - |
16
|
$42.98 | Buy/Sell | $43.00 | -100.00% | 0 | $2.64B |
| INDV | Indivior PLC | Buy |
14
|
£13.37 | Buy/Sell | £28.89 | 131.34% | 4 | £1.95B |
| ALM | Almirall | Outperform |
16
|
9.27€ | Buy/Sell | 11.39€ | 18.66% | 3 | 1.94€B |
| GLPG | Galapagos NV | Hold |
6
|
27.50€ | Buy/Sell | 39.85€ | 25.45% | 2 | 1.80€B |
| APPS | Applus Services | Outperform |
15
|
12.72€ | Buy/Sell | 10.92€ | -6.05% | 3 | 1.63€B |
| CLIN | Clinigen | - |
18
|
£9.25 | Buy/Sell | £7.78 | -100.00% | 0 | £1.23B |
| BIO3 | Biotest | Hold |
9
|
27.60€ | Buy/Sell | 37.00€ | 34.06% | 0 | 1.38€B |
| VEC | Vectura Group | - |
14
|
£165.00 | Buy/Sell | £1.55 | -100.00% | 0 | £1.00B |
| COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF72.90 | Buy/Sell | CHF76.55 | 28.34% | 0 | CHF1.14B |
| FAE | Faes Farma | Hold |
18
|
3.66€ | Buy/Sell | 3.90€ | -0.27% | 0 | 1.09€B |
| 4544 | H.U. Group Holdings | Outperform |
17
|
¥2.69k | Buy/Sell | ¥0.00 | -7.05% | 0 | ¥164.15B |
| ERGO | Ergomed | - |
16
|
£9.84 | Buy/Sell | £14.90 | -100.00% | 0 | £490.82M |
| PHM | Pharma Mar | Outperform |
13
|
36.72€ | Buy/Sell | 50.20€ | 30.72% | 1 | 536.95€M |
| BSLN | Basilea Pharmaceutica | Outperform |
6
|
CHF43.65 | Buy/Sell | CHF65.63 | 51.20% | 0 | CHF529.94M |
| NIOX | NIOX Group Plc | Buy |
6
|
£0.73 | Buy/Sell | £0.76 | 5.48% | 0 | £301.02M |
| DBV | DBV Technologies | Outperform |
5
|
1.27€ | Buy/Sell | 4.07€ | 214.96% | 1 | 115.65€M |
| MOLN | Molecular Partners | Outperform |
4
|
CHF3.31 | Buy/Sell | CHF9.50 | 182.48% | 1 | CHF110.77M |